RhumbLine Advisers’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$408K Buy
86,546
+647
+0.8% +$3.05K ﹤0.01% 2807
2025
Q1
$394K Sell
85,899
-5,040
-6% -$23.1K ﹤0.01% 2727
2024
Q4
$436K Buy
90,939
+827
+0.9% +$3.96K ﹤0.01% 2758
2024
Q3
$423K Sell
90,112
-9,442
-9% -$44.3K ﹤0.01% 2815
2024
Q2
$562K Buy
99,554
+1,230
+1% +$6.95K ﹤0.01% 2589
2024
Q1
$404K Sell
98,324
-1,682
-2% -$6.91K ﹤0.01% 2796
2023
Q4
$422K Sell
100,006
-1,935
-2% -$8.17K ﹤0.01% 2770
2023
Q3
$440K Sell
101,941
-100,767
-50% -$435K ﹤0.01% 2684
2023
Q2
$1.34M Buy
202,708
+9,100
+5% +$60K ﹤0.01% 2144
2023
Q1
$1.32M Buy
193,608
+8,485
+5% +$57.6K ﹤0.01% 2012
2022
Q4
$1.37M Buy
185,123
+9,481
+5% +$70.1K ﹤0.01% 1984
2022
Q3
$1.74M Buy
175,642
+614
+0.4% +$6.07K ﹤0.01% 1840
2022
Q2
$1.91M Buy
175,028
+9,611
+6% +$105K ﹤0.01% 1788
2022
Q1
$1.87M Sell
165,417
-3,149
-2% -$35.6K ﹤0.01% 1851
2021
Q4
$2.65M Sell
168,566
-2,743
-2% -$43K ﹤0.01% 1733
2021
Q3
$2.94M Sell
171,309
-20,415
-11% -$350K ﹤0.01% 1672
2021
Q2
$4.12M Sell
191,724
-9,147
-5% -$197K 0.01% 1522
2021
Q1
$3.02M Sell
200,871
-309
-0.2% -$4.64K ﹤0.01% 1701
2020
Q4
$2.64M Buy
201,180
+17,873
+10% +$235K ﹤0.01% 1707
2020
Q3
$1.77M Sell
183,307
-15,573
-8% -$150K ﹤0.01% 1746
2020
Q2
$2.28M Buy
198,880
+23,350
+13% +$267K ﹤0.01% 1657
2020
Q1
$1.82M Buy
175,530
+3,163
+2% +$32.8K ﹤0.01% 1601
2019
Q4
$2.83M Buy
172,367
+8,770
+5% +$144K ﹤0.01% 1596
2019
Q3
$2.17M Buy
163,597
+4,995
+3% +$66.3K ﹤0.01% 1697
2019
Q2
$2.24M Buy
158,602
+8,653
+6% +$122K ﹤0.01% 1675
2019
Q1
$2.76M Buy
149,949
+832
+0.6% +$15.3K 0.01% 1524
2018
Q4
$3.9M Buy
149,117
+12,196
+9% +$319K 0.01% 1250
2018
Q3
$3.14M Buy
136,921
+85,370
+166% +$1.96M 0.01% 1413
2018
Q2
$982K Buy
51,551
+9,365
+22% +$178K ﹤0.01% 2019
2018
Q1
$711K Sell
42,186
-1,010
-2% -$17K ﹤0.01% 2082
2017
Q4
$657K Sell
43,196
-8,125
-16% -$124K ﹤0.01% 2124
2017
Q3
$919K Buy
51,321
+600
+1% +$10.7K ﹤0.01% 2018
2017
Q2
$827K Buy
50,721
+6,299
+14% +$103K ﹤0.01% 2043
2017
Q1
$622K Buy
44,422
+1,550
+4% +$21.7K ﹤0.01% 2157
2016
Q4
$684K Buy
42,872
+3,188
+8% +$50.9K ﹤0.01% 2055
2016
Q3
$660K Sell
39,684
-4,750
-11% -$79K ﹤0.01% 2046
2016
Q2
$497K Sell
44,434
-1,259
-3% -$14.1K ﹤0.01% 2197
2016
Q1
$382K Buy
45,693
+1,285
+3% +$10.7K ﹤0.01% 2392
2015
Q4
$413K Buy
44,408
+2,515
+6% +$23.4K ﹤0.01% 2370
2015
Q3
$473K Buy
41,893
+283
+0.7% +$3.2K ﹤0.01% 2260
2015
Q2
$528K Buy
41,610
+2,965
+8% +$37.6K ﹤0.01% 2289
2015
Q1
$359K Buy
38,645
+9,625
+33% +$89.4K ﹤0.01% 2509
2014
Q4
$416K Sell
29,020
-775
-3% -$11.1K ﹤0.01% 2387
2014
Q3
$309K Hold
29,795
﹤0.01% 2502
2014
Q2
$482K Buy
29,795
+1,273
+4% +$20.6K ﹤0.01% 2298
2014
Q1
$463K Sell
28,522
-1,280
-4% -$20.8K ﹤0.01% 2276
2013
Q4
$370K Buy
29,802
+1,810
+6% +$22.5K ﹤0.01% 2438
2013
Q3
$307K Buy
27,992
+1,412
+5% +$15.5K ﹤0.01% 2512
2013
Q2
$215K Buy
+26,580
New +$215K ﹤0.01% 2937